<DOC>
	<DOCNO>NCT01834677</DOCNO>
	<brief_summary>The purpose study evaluate psychometric property utility new , computerized , neurocognitive measure human depression , human depression undergo electroconvulsive therapy ( ECT ) . The benefit study outweigh risk possibility develop good computerize neurocognitive measure , risk limit minimal test relate fatigue psychological stress . Depressed human , depress human participant undergo ECT , human diagnose Parkinson 's disease ( age 18-85 ) invite participate study . After provide informed consent participant undergo clinical psychiatric evaluation confirm inclusion/exclusion criterion . After clinical psychiatric evaluation , participant complete common new neurocognitive measure . There total two test visit ( baseline , 1-month follow-up ) . The anticipated duration participant 's involvement 2 study visit take place 4-day period ( i.e. , clinical evaluation occur day 1 neuropsychological measure administer day 2 study visit ) equate approximately 6-hours ( 3-hours day ) per study visit .</brief_summary>
	<brief_title>Translational Research Evaluating Neurocognitive Memory Processes</brief_title>
	<detailed_description />
	<criteria>Depressed Individuals 1 . Male female subject , age 1885 2 . DSMIVTR diagnosis major depressive episode , unipolar , confirmed MINIPLUS [ 221 ] 3 . HRSD24 total score &gt; 10 4 . MMSE total score &gt; 26 5 . Graduated high school 6 . Competent provide inform consent Depressed Individuals Receiving ECT 1 . Same Depressed Cohort Inclusion Criteria ( see ) 2 . Referred ECT 3 . Subject competent provide inform consent Individuals Diagnosed PD 1 . Male female subject , age 1885 2 . Diagnosed PD 3 . MMSE total score &gt; 20 4 . Graduate high school 5 . Subject competent provide inform consent Depressed Individuals/Depressed Individuals Receiving ECT 1 . Lifetime history bipolar disorder , schizophrenia , schizoaffective disorder , mental retardation 2 . Current neurostimulation treatment ( e.g. , ECT , MST , rTMS , vagus nerve stimulation , deep brain stimulation ) 3 . Current alcohol abuse dependence within past 12 month 4 . Current substance abuse dependence within past 12 month 5 . Lifetime mental retardation 6 . History central nervous system ( CNS ) disease 7 . Current diagnosis dementia delirium 8 . Current visual , auditory , motor impairment compromise ability take test 9 . Unable read comprehend English Individuals Diagnosed PD 1 . Lifetime history bipolar disorder , schizophrenia , schizoaffective disorder , mental retardation 2 . Current neurostimulation treatment ( e.g. , ECT , MST , rTMS , vagus nerve stimulation , deep brain stimulation ) 3 . Current alcohol abuse dependence within past 12 month 4 . Current substance abuse dependence within past 12 month 5 . Lifetime mental retardation 6 . History central nervous system ( CNS ) disease Parkinson 's Disease 7 . Current diagnosis dementia delirium 8 . Current visual , auditory , motor impairment compromise ability take test 9 . Unable read comprehend English</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Depression</keyword>
	<keyword>Neurocognition</keyword>
	<keyword>Electroconvulsive Therapy ( ECT )</keyword>
	<keyword>Parkinson 's Disease</keyword>
</DOC>